Health Care Spending Gone Wild: Using Expensive Insulin Analogs With Few Clinical Advantages

Health Care Spending Gone Wild: Using Expensive Insulin Analogs With Few Clinical Advantages

Health care spending in the United States is out of control. The most significant aspect of medical care driving this spending is pharmaceuticals; within pharmaceuticals the greatest increases have been in spending for diabetes medications. The cost of insulin analogs has increased 5- to 6-fold in the last 10 years for no particular reason. More than 90% of US patients who use insulin use these analogs, despite the fact that they have few if any clinical benefits relative to regular or NPH insulin, which cost 1/10 as much. Aside from the cost of insulin, diabetes is probably treated far more aggressively than necessary since clinical trials demonstrating the benefits of aggressive glucose control for type 2 diabetes demonstrated vanishingly small benefits of this form of treatment. In this podcast we discuss the perplexing case of spending too much money on diabetes treatment.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(499)

An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)

An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)

POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated 0.1% to 1% of the US population. Author Satish Raj, MD, MSCI,...

24 Elo 28min

Medication Treatments for Alcohol Use Disorder

Medication Treatments for Alcohol Use Disorder

Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment of alcohol use disorder. Author Stephen Holt, MD, MS, of Yale School of Medicine joins JAMA De...

19 Elo 20min

Liquid Biopsy Tests for Cancer

Liquid Biopsy Tests for Cancer

Circulating tumor DNA (ctDNA)(liquid biopsies) can help monitor cancer progression, detect residual cancer after treatment, and identify genetic changes within cancer cells that could affect treatment...

10 Elo 23min

Patient-Clinician Communication About Physical Activity

Patient-Clinician Communication About Physical Activity

Physical activity is an effective component of care for people with chronic medical conditions. In this podcast, JAMA Insights author Alessio Bricca, PhD, University of Southern Denmark, discusses ada...

6 Elo 10min

Classic Hodgkin Lymphoma

Classic Hodgkin Lymphoma

Hodgkin lymphoma is a relatively rare disease, with approximately 82 409 incident cases reported globally in 2022, and 8720 cases reported in the US in 2025. Author Alison Moskowitz, MD, of Memorial S...

3 Elo 20min

The Sleep-Weight Connection

The Sleep-Weight Connection

Suboptimal sleep quality and quantity are associated with higher body mass index and more difficulty losing weight. In this podcast, JAMA Insights author Atul Malhotra, MD, from the University of Cali...

29 Heinä 13min

Management of Dyslipidemia

Management of Dyslipidemia

Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author A...

20 Heinä 23min

Hip Fractures: Management and Prevention

Hip Fractures: Management and Prevention

Hip fractures are a leading cause of disability and death in older adults. This episode summarizes  risk factors, prevention, and medical and surgical management of  hip fractures. JAMA Deputy Editor ...

16 Heinä 19min

Suosittua kategoriassa Tiede

rss-poliisin-mieli
tiedekulma-podcast
rss-mita-tulisi-tietaa
docemilia
utelias-mieli
rss-duokkari-ekstra
hippokrateen-vastaanotolla
rss-ylistys-elaimille
rss-hereilla
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
rss-sotepodi-ratkaisuja-hyvinvointiin
rss-duodecim-lehti
rss-kasvikutsut
rss-tervetta-skeptisyytta
rss-totuuden-liepeilla
rss-bios-podcast
filocast-filosofian-perusteet
rss-tiedetta-vai-tarinaa